Nyxoah
ExitedImplantable neuro-stimulator chip for obstructive sleep apnea
Nyxoah has raised €66M across 4 funding rounds from 3 investors, most recently a round in Dec 2020. Based in Mont-Saint-Guibert, Belgium; founded 2009; active in Healthtech. The company has exited (2020). Data as of 28 Oct 2026.
Total raised
€66M
€66,000,000
Funding rounds
4
Investors
3
distinct backers
Active since
2014-05
latest 2020-12
Funding by year
EUR raised per yearNyxoah — funding by year — interactive chart.
Data table
| Nyxoah — funding by year | |
|---|---|
| 2014 | €8.0M |
| 2016 | €18M |
| 2018 | €15M |
| 2020 | €25M |
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-12-02 | Other | €25M | — | View deal → |
| 2018-11-13 | Other | €15M | Cochlear Limited | View deal → |
| 2016-07-01 | Series B | €18M | Gilde Healthcare,S.R.I.W - Societe Regionale d Investissement de Wallonie | View deal → |
| 2014-05-01 | Series A | €8.0M | — | View deal → |
Exit
Type
ipo
Date
Sep 2020
Value
—
Acquiror
—
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData